NEW YORK (GenomeWeb) – Advanced Clinical Laboratory Solutions (ACLS) announced today that it has signed a contract to provide clinical toxicology and pharmacogenetics testing to third-party administrator POMCO.
Specific terms of the arrangement, which became effective August 1, were not disclosed.
"We selected ACLS as a participating national laboratory network provider based upon its capabilities for offering physicians and their patients greater access to high-quality toxicology testing at smaller laboratory facilities throughout the country," Steven O'Brien, executive director of network development at POMCO, said in a statement.